ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Omeros Corporation

Omeros Corporation (OMER)

3.88
0.03
(0.78%)
Closed July 04 4:00PM
3.81
-0.07
(-1.80%)
After Hours: 4:13PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.88
Bid
3.80
Ask
4.00
Volume
66,864
3.81 Day's Range 3.96
0.92 52 Week Range 5.84
Market Cap
Previous Close
3.85
Open
3.86
Last Trade Time
Financial Volume
$ 259,291
VWAP
3.8779
Average Volume (3m)
333,583
Shares Outstanding
57,944,159
Dividend Yield
-
PE Ratio
-1.91
Earnings Per Share (EPS)
-2.03
Revenue
-
Net Profit
-117.81M

About Omeros Corporation

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injec... Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Tumwater, Washington, USA
Founded
1970
Omeros Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OMER. The last closing price for Omeros was $3.85. Over the last year, Omeros shares have traded in a share price range of $ 0.92 to $ 5.84.

Omeros currently has 57,944,159 shares outstanding. The market capitalization of Omeros is $224.82 million. Omeros has a price to earnings ratio (PE ratio) of -1.91.

OMER Latest News

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, June 6, 2024, starting...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.020.5181347150263.864.09943.742883803.9669747CS
40.010.2583979328173.874.413.73720383.95884737CS
120.43512.62699564593.4454.412.9653335833.68106164CS
260.5917.93313069913.295.1352.764650323.75859247CS
52-1.57-28.80733944955.455.840.925515803.13946876CS
156-11.1-74.098798397914.9816.570.927646805.05255106CS
260-11.49-74.756018217315.3725.490.927454429.02655178CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KOSSKoss Corporation
$ 10.63
(143.81%)
70.06M
JEWLAdamas One Corporation
$ 0.4615
(89.14%)
6.58M
VVPRVivoPower International PLC
$ 2.50
(66.67%)
55.79M
DOYUDouYu International Holdings Ltd
$ 17.94
(42.49%)
5.25M
AHGAkso Health Group
$ 1.155
(40.51%)
520k
SHPWShapeways Holdings Inc
$ 0.2693
(-61.86%)
1.99M
SONMSonim Technologies Inc
$ 0.5507
(-42.34%)
1.47M
SHOTWSafety Shot Inc
$ 0.18
(-35.71%)
2.01k
AMIXAutonomix Medical Inc
$ 0.6415
(-31.76%)
19.59M
VIVKVivakor Inc
$ 2.31
(-31.66%)
368.29k
NVDANVIDIA Corporation
$ 128.28
(4.57%)
215.8M
ZCARZoomcar Holdings Inc
$ 0.183
(33.97%)
204.3M
MAXNMaxeon Solar Technologies Ltd
$ 0.1736
(-3.50%)
202.28M
TSLATesla Inc
$ 246.39
(6.54%)
166.56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.02
(13.16%)
86.38M

OMER Discussion

View Posts
Monksdream Monksdream 9 months ago
OMER new 52=week low
Then bounce
πŸ‘οΈ0
shurtha2000 shurtha2000 9 months ago
$341M cash and $12M recievables
πŸ‘οΈ0
starkd748 starkd748 1 year ago
Gap filled 6s 7s next top
πŸ‘οΈ0
Roadtojourney Roadtojourney 1 year ago
With the type of news this should have been above 5 not sure whats wrong here?
πŸ‘οΈ0
starkd748 starkd748 1 year ago
3.20 gap must fill now
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
OMER $200M PAYMENT
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$OMER: She back on fire now............ sheeeshhhhhhhhhhhhhh


Go baby goooooooooo.......... $3 breaker upside




GO $OMER
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Weeeeeeee
πŸ‘οΈ0
starkd748 starkd748 2 years ago
We get some 5s I'm backing up the truck
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Was a good trade but it's been done since 7s
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Weeeeee
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Weeeeeeeeeeeee
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Yesss
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Looking good
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Weeeeee
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Yesss
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Bounced off the low 3s time to load
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Maybe an A B C ... 2.17 might coming
πŸ‘οΈ0
starkd748 starkd748 2 years ago
Not ready yet
πŸ‘οΈ0
starkd748 starkd748 2 years ago
I like this at a certain fib level hehehe
πŸ‘οΈ0
bandit007 bandit007 2 years ago
Great day here! $OMER
πŸ‘οΈ0
bandit007 bandit007 2 years ago
Breaking out!
πŸ‘οΈ0
bandit007 bandit007 2 years ago
Looking good here. Steady climb
πŸ‘οΈ0
bandit007 bandit007 2 years ago
Looking good here. Steady climb
πŸ‘οΈ0
Scott 75 Scott 75 3 years ago
Wow! Thanks for sharing. I can't believe with all that going for it and the price is so beaten down.
πŸ‘οΈ0
Nefyn Nefyn 3 years ago
So what happens to OMER…a public company with tons of cash and no business operations?
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
Bahhh Bahhh

gonna do this all day long
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
another round for the apes Lets GO !!
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
Glad I'm just a robot no emotions needed
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
Fk with BB My new addiction
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
IN now I'm gonna tick flip this POS to death
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
Trying for the baseline
no holds barred..
πŸ‘οΈ0
Jess070283 Jess070283 3 years ago
Load it up!$$$
πŸ‘οΈ0
TheGreenReaper TheGreenReaper 3 years ago
OMER$$$$
πŸ‘οΈ0
Golden Cross Golden Cross 3 years ago
$14 Targeting
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
59M trading float. Huge news out >
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Shorts feeling the heat!!!!! >
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
>>>>> GANGBUSTERS <<<<< $$$$$

OMER
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
OMER > That is a sweet revenue deal. OMER heading to $20.00+
$125 million upfront payment and $200 million on achievement of commercial milestone
Royalties of 50% on U.S. net sales until the earlier of either January 1, 2025 or payment of the $200-million milestone, after which royalties adjust to 30% of U.S. net sales
Royalties of 15% on ex-U.S. net sales
OMIDRIA to become a premier product in Rayner’s ophthalmology franchise
In addition to acquiring the OMIDRIA commercial organization, including the current OMIDRIA sales force, Rayner plans to further expand its U.S. and ex-U.S. sales forces
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
https://ih.advfn.com/stock-market/NASDAQ/omeros-OMER/stock-news/86711139/omeros-announces-agreement-to-sell-omidria-franch
πŸ‘οΈ0
Frankestin Frankestin 3 years ago
Here are the 5!
Very interesting if it goes under!
I would be tempted to open the position now!
πŸ‘οΈ0
Frankestin Frankestin 3 years ago
Someone says 5 ... will it get there?
I would like to enter but of course they spend a lot on research and development... and for sell
πŸ‘οΈ0
Frankestin Frankestin 3 years ago
ooOOoo
I take a handful these days!
πŸ‘οΈ0
Termite7 Termite7 3 years ago
Buying opportunity???
πŸ‘οΈ0
frugalNorwegian frugalNorwegian 3 years ago
I created a page on my site talking about OMER. Let me know if I am missing any nuggets. Thanks.

https://frugalnorwegian.com/omer

Summary: This company is a prime candidate for a buyout if FDA approval is given.
πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 3 years ago
If one is worried about fda's delay, Check out @alanrobertross message on StockTwits http://stocktwits.com/alanrobertross/message/333077805
πŸ‘οΈ0
umiak umiak 3 years ago
Tute ownership up to 78% been hovering around 50% for years. 20% short
πŸ‘οΈ0
umiak umiak 3 years ago
Not new news but I like the smart reporting style:
Omeros's Biologics License Application for Blood Vessel Damage Treatment Candidate Accepted for Priority Review by FDA

1/19/21, 8:06 AM
10:06 AM EST, 01/19/2021 (MT Newswires) -- Omeros (OMER) said Tuesday its biologics license application for narsoplimab, a potential treatment for transplant-associated thrombotic microangiopathy, has been accepted for priority review by the US Food and Drug Administration.

Thrombotic microangiopathy is characterized by a pattern of damage in the small blood vessels.

The FDA has set the Prescription Drug User Fee Act action date on July 17.
πŸ‘οΈ0
umiak umiak 3 years ago
Have you looked at NLST? Short story:

*google signed a NDA with NLST to use their seminal technology
*google was bad even lied to court
*they lost their appeal
*google let date to file with scotus pass
*now one way or another they must pay
*one way to pay--google's case and settlement with ADT(eye opening)
*another way to pay-- Centripetal v Cisco (cisco was bad for 3 yrs
google is on the hook for 11 yrs)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160597164
*estimate to file to lift stay Q1 2021
*bought dips as low as .48 keep adding
*yahoo board and ihub board are bullish
lots of speculation but also good info.
*there are active cases with other companies Sk-hynic recently lost
on 2 parts of patent 907
*scheduled markman for infringement of (NLST)patents 218 and 595 3/9/2021
trial, if defendants choose, 12/2021
*it is a popping year for NLST they have been chasing google in court for 11 yrs, google will have to settle.
πŸ‘οΈ0
umiak umiak 3 years ago
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock